News Roche poised to buy MASH drug developer 89bio for $3.5bn Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its phase 3 candidate pegozafermin for MASH.
News Google adds insulin resistance tracker to wearables In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.